- Home
- BAX vs ENSG Comparison
BAX vs ENSG Comparison
Compare BAX & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAX | ENSG |
|---|---|---|
| Founded | 1931 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.7B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BAX | ENSG |
|---|---|---|
| Price | $20.09 | $160.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $21.00 | ★ $202.60 |
| AVG Volume (30 Days) | ★ 6.6M | 905.0K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.24% | 0.14% |
| EPS Growth | N/A | ★ 14.06 |
| EPS | N/A | ★ 1.67 |
| Revenue | ★ $11,244,000,000.00 | $5,057,841,000.00 |
| Revenue This Year | $1.96 | $17.07 |
| Revenue Next Year | $2.22 | $9.49 |
| P/E Ratio | ★ N/A | $93.88 |
| Revenue Growth | 5.72 | ★ 18.72 |
| 52 Week Low | $15.73 | $134.80 |
| 52 Week High | $31.76 | $218.00 |
Technical Indicators
Market Signals| Indicator | BAX | ENSG |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | 44.80 |
| Support Level | $18.95 | $141.58 |
| Resistance Level | $21.28 | $183.89 |
| Average True Range (ATR) | 0.66 | 7.04 |
| MACD | -0.05 | 0.93 |
| Stochastic Oscillator | 56.77 | 60.43 |
Price Performance
Historical ComparisonAbout BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.